Conference - Innovation systems and prospects of health

The conference aims at highlighting the currently ongoing initiatives to support the development of innovative medicines and making patient’s access to new treatments easier and more rapid.

This conference stems from the need to collect and offer a comprehensive presentation of all initiatives undertaken in this area by the EU institutions, through the work programmes of the European Medicines Agency (EMA) ,the IMI projects of the European Commission, the work carried out by DG Enterprise on orphan drugs, as well as the developments in the use of instruments of Health Technology Assessment (HTA) for the evaluation of the relative effictiveness of medicinal products.

In collaboration with: Italian Medicines Agency